Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RGA | Common Stock | Options Exercise | $78.8K | +1K | +6.48% | $78.48 | 16.5K | May 10, 2023 | Direct | |
transaction | RGA | Common Stock | Tax liability | -$48.4K | -328 | -1.99% | $147.42 | 16.2K | May 10, 2023 | Direct | F1 |
transaction | RGA | Common Stock | Sale | -$100K | -676 | -4.18% | $148.41 | 15.5K | May 10, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RGA | Stock Appreciation Right (right to purchase) 2014 | Options Exercise | $0 | -2.15K | -100% | $0.00* | 0 | May 10, 2023 | Common Stock | 2.15K | $78.48 | Direct | F2 |
Id | Content |
---|---|
F1 | Represents (i) 1,143 shares sold to pay the exercise price the purchase of common stock, and (ii) 328 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 676 shares. |
F2 | SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |